WPI 3355 (Nateglinide 120 mg)

Pill imprint WPI 3355 has been identified as Nateglinide 120 mg.

Nateglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nateglinide

Imprint:

WPI 3355

Strength:

120 mg

Color:

Pink

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Meglitinides

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Laboratories Inc.

National Drug Code (NDC):

00591-3355

Inactive Ingredients:

silicon dioxide colloidal
fumaric acid
hypromellose 2910 (3 mPa.s)
lactose monohydrate
magnesium stearate
polysorbate 80
sodium starch glycolate type A potato
corn starch
titanium dioxide
hypromellose 2910 (6 mPa.s)
FD&C Red No. 40
aluminum oxide
ferric oxide red
ferric oxide black

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.